What is ARMR Systems?
ARMR Systems, Inc. operates at the intersection of medical device engineering and emergency response, specializing in advanced hemorrhage control solutions. The company's flagship innovation, the XT1, is a wearable system engineered to facilitate rapid, effective bleeding control without requiring extensive medical training. By focusing on the democratization of trauma care, ARMR Systems addresses the urgent need for reliable, user-friendly tools in pre-hospital settings, where every second is critical to patient survivability. Their market position is defined by a commitment to rigorous design standards and collaborative development with clinical experts, establishing the firm as a key player in the evolving landscape of emergency medical technology.
How much funding has ARMR Systems raised?
ARMR Systems has raised a total of $1.8M across 2 funding rounds:
Angel/Seed
$750K
Private Equity
$1.1M
Angel/Seed (2020): $750K with participation from Tamiami Angel Funds, University of Maryland, Baltimore, and Maryland Momentum Fund
Private Equity (2025): $1.1M, investors not publicly disclosed
Key Investors in ARMR Systems
Tamiami Angel Funds
A private equity firm specializing in early-stage capital investment, supporting entrepreneurs and small businesses with high-growth potential.
University of Maryland, Baltimore
A leading academic research institution focused on advancing medical science and fostering innovation through strategic partnerships.
Maryland Momentum Fund
An investment vehicle dedicated to supporting technology-based startups affiliated with the University System of Maryland.
What's next for ARMR Systems?
With the successful closure of this major strategic investment, ARMR Systems is poised to scale its operational capacity and expand its market reach. The company is expected to prioritize the mass production and distribution of the XT1 system, targeting both civilian emergency services and specialized defense sectors. Future strategic initiatives will likely focus on clinical validation studies and the integration of their hemorrhage control technology into broader emergency response protocols. As the company transitions into this next phase of growth, the focus remains on enhancing survivability outcomes through technological innovation, solidifying its role as a leader in the trauma care sector.
See full ARMR Systems company page
